NEWS

October 21, 2019

pH Pharma and Immunome Enter into Collaboration and License Agreement to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates in Oncology

June 24, 2019

Immunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer

October 6, 2016

Immunome Raises $5 Million Series A Financing to Advance Novel Cancer Immunotherapies

April 20, 2016

Immunome Appoints Michael J. Morin, PhD, as President and Chief Scientific Officer

[/vc_row]
© 2019 Immunome Inc. All Rights Reserved.